Motif ID: Dlx5_Dlx4
Z-value: 1.876


Transcription factors associated with Dlx5_Dlx4:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Dlx4 | ENSMUSG00000020871.7 | Dlx4 |
Dlx5 | ENSMUSG00000029755.9 | Dlx5 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Dlx5 | mm10_v2_chr6_-_6882068_6882092 | -0.74 | 2.3e-03 | Click! |
Top targets:
Showing 1 to 20 of 200 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 221 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 10.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
2.0 | 9.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 8.2 | GO:0010842 | retina layer formation(GO:0010842) |
2.1 | 6.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 5.9 | GO:0008347 | glial cell migration(GO:0008347) |
1.8 | 5.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 4.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.1 | 3.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 3.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.2 | 3.1 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 3.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.8 | 3.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 3.0 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 2.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 2.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 2.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 2.8 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.9 | 2.7 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 2.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.3 | 2.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
Gene overrepresentation in cellular_component category:
Showing 1 to 20 of 100 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 10.7 | GO:0030425 | dendrite(GO:0030425) |
0.4 | 9.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 5.9 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 5.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 5.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 4.8 | GO:0043034 | costamere(GO:0043034) |
0.1 | 4.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 3.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.7 | 3.7 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 3.4 | GO:0031672 | A band(GO:0031672) |
0.1 | 3.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 3.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 2.7 | GO:0043235 | receptor complex(GO:0043235) |
0.6 | 2.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 2.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 2.1 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 2.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 1.7 | GO:0001741 | XY body(GO:0001741) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 132 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 15.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 11.1 | GO:0003779 | actin binding(GO:0003779) |
3.4 | 10.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 6.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 5.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 5.5 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 5.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 4.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 3.7 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
1.1 | 3.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
1.0 | 3.0 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.7 | 2.9 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 2.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 2.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 2.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 2.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 2.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 2.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 2.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |